Melanoma News and Research

Latest Melanoma News and Research

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

A novel anticancer molecule created by researchers at The Wistar Institute showed therapeutic activity in preclinical models of various cancer types.

3 Oct 2019

Adding local anesthetics can improve treatment for incurable breast cancer, melanoma

A new study examined the effects of local anesthetics combined with standard chemotherapy for treatment of incurable triple-negative breast cancer, as well as melanoma.

3 Oct 2019

Discovery of neoantigens could widen the possibilities for universal cancer vaccine

For more than a decade, scientist Stephen Albert Johnston and his team at Arizona State University's Biodesign Institute have pooled their energies into an often scoffed-at, high-risk, high-reward goal in medicine: to develop a universal vaccine to prevent cancer.

2 Oct 2019

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.

30 Sep 2019

A new method to distinguish benign and cancerous skin moles

A new study has reported a cost-effective, more accurate, and less invasive way to diagnose cancerous melanoma cells in skin tumors.

30 Sep 2019

New method can help detect melanoma cells in skin tumors

Melanoma is the least common but one of the most deadly skin cancers. It accounts for only about one percent of all cases globally, but the majority of skin cancer deaths.

30 Sep 2019

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

A combination of two immunotherapy drugs, ipilimumab and nivolumab, has stopped or reversed the progression of advanced melanoma for five years or more in one in two patients, according to a study led by The Royal Marsden NHS Foundation Trust.

28 Sep 2019

Pioneering melanoma test to be made available within two years

Scientists have developed a pioneering new test that can more accurately predict whether melanoma, a type of skin cancer, is likely to return.

27 Sep 2019

DataArt launches 'SkinCareAI' prototype app to detect early signs of melanoma

Global technology consultancy DataArt announced today the launch of “SkinCareAI” - a prototype app that analyses skin images to detect early signs of melanoma.

27 Sep 2019

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer and kidney cancer.

26 Sep 2019

Investigational drug may offer new treatment option for patients with lung and kidney cancer

26 Sep 2019

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

25 Sep 2019

Johns Hopkins researchers link a gene to melanoma growth and spread

Using a small noncoding RNA, microRNA 211, and tools that track the stability and decay of the protein-coding and noncoding RNAs in lab-grown melanoma cells, a team led by a Johns Hopkins Kimmel Cancer Center researcher identified highly unstable RNA molecules in human melanomas, including a novel miR-211 target gene DUSP3.

From Johns Hopkins Medicine 25 Sep 2019

Openspecimen chosen to manage ARTB's biospecimen library

The Auckland Region Tissue Bank is a critical component in New Zealand’s medical research infrastructure. As a central facility for storing blood and tissue samples, they have a library that could hold the secrets to unlocking cures for existing and future chronic diseases and illnesses.

25 Sep 2019

New method harnesses the power of killer T cells to attack tumor cells, treat cancer

They've been called the "special forces" of the immune system: invariant natural killer T cells. Although there are relatively few of them in the body, they are more powerful than many other immune cells.

24 Sep 2019

Research may provide better tools for designing personalized protocols for cancer patients

Diversity – at least among cancer cells – is not a good thing. Now, research from the Weizmann Institute of Science shows that in melanoma, tumors with cells that have differentiated into more diverse subtypes are less likely to be affected by the immune system, thus reducing the chance that immunotherapy will be effective.

17 Sep 2019

New method developed to address failures in promising anti-cancer drug

Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and biomaterials science to improve the efficacy, accuracy and longevity of certain cancer therapies.

17 Sep 2019

B-cell subtypes play essential role in immune response to melanoma

When it comes to further developing modern immunotherapies, cancer research has so far concentrated on T-lymphocytes.

13 Sep 2019

B cells may play an important role in immunotherapy for melanoma

Researchers at EMBL's European Bioinformatics Institute and the Medical University of Vienna have found evidence that B cells might play an important role in immunotherapy for melanoma.

13 Sep 2019

SkinVision algorithm detects 95% of skin cancer, study finds

An international group of researchers working with Erasmus University Medical Center (Erasmus MC) in the Netherlands determined that SkinVision – the first CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer.

13 Sep 2019

Melanoma News and Research

Latest Melanoma News and Research

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

Adding local anesthetics can improve treatment for incurable breast cancer, melanoma

Discovery of neoantigens could widen the possibilities for universal cancer vaccine

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

A new method to distinguish benign and cancerous skin moles

New method can help detect melanoma cells in skin tumors

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

Pioneering melanoma test to be made available within two years

DataArt launches 'SkinCareAI' prototype app to detect early signs of melanoma

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

Johns Hopkins researchers link a gene to melanoma growth and spread

Openspecimen chosen to manage ARTB's biospecimen library

New method harnesses the power of killer T cells to attack tumor cells, treat cancer

Research may provide better tools for designing personalized protocols for cancer patients

New method developed to address failures in promising anti-cancer drug

B-cell subtypes play essential role in immune response to melanoma

B cells may play an important role in immunotherapy for melanoma

SkinVision algorithm detects 95% of skin cancer, study finds

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Melanoma News and Research

Latest Melanoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in